SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

Scientific Committee

Over 20 Subcommittees powering the therapeutics and tech innovation research and initiatives.

Scientific Committee

The Alzheimer’s Disease and Dementia SBMT Subcommittee, focuses on research on novel early diagnostics, therapeutics and management of Alzheimer’s disease and neurodegenerative diseases and dementia.

The Autism and Pediatric Neuroscience SBMT Subcommittee focuses on research on autism spectrum disorder and pediatrics neurological diseases, their implications diagnostics and therapeutics.

The Cerebrovascular and Skull base Surgery SBMT Subcommittee encompasses the divisions of neurosurgery, interventional neuroradiology, and AI endovascular surgery, all of which focus on a multidisciplinary approach to the treatment and care of various neurovascular diseases.

The Epilepsy, EEG, MEG, and NeuroRadiology SBMT Subcommittee, focuses on the functional aspects of neuro-imaging and associated research. MRI, MEG, PET, nuclear medicine, MRSI, MR-PET, DTI, CT-PET, focused ultrasound, MSI/MEG, ultra-high and low field MRI and interventional radiology, neurooncology, SRS, Gamma-Knife, Cyberknife, ZAP.

The Military Medicine and Veterans Health focuses on research regarding health for wounded soldiers and improvement of quality of life. PTSD, Traumatic Brain Injury, Mental Health, Neurotechnology, prosthetics, and Neurotrauma.

The NanoneuroSurgery and NeuroPhotonics SBMT Subcommittee focuses on research on the newest advances on nanotechnology for the purpose of neurosurgery and neurology. This subcommittee also explores the novel phtotonic applications in neurology and neurosciences in general.

The Neurooncology and Stem Cell SBMT Subcommittee, focuses on research on Brain cancer such as Glioblastoma, Astrocytoma and Meningiomas, their early molecular diagnosis, different therapeutic modalities (chemotherapy, radiation oncology, biologics, immunotherapy)

The Neuropsychiatric and Innovation SBMT Subcommittee, focuses on research on addiction, anxiety disorder, autism, sleep, medical imaging for psychiatric conditions, schizophrenia, depression, PTSD.

The Neuroscience20 SBMT Initiative subcommittee focuses on the global economical burden of neurological diseases and formulates resolutions given to the G20 leaders. It also leads an annual summit that is a think tank that serves this purpose, engaging in business plan workshops, health care policy issues that affect treatment delivery, usage of certain devices/drugs/imaging technologies, FDA regulations and reimbursements, federal and regional regulation impacting health care delivery and research funding, initiative and congressional legislation.

The Neurotechnology, Brain Computer Interface and Neuroengineering SBMT Subcommittee is for those who want to see the future, today. It dwells on the latests technological advances applied to neurosciences in general. AI Machine Learning.

The Psychedelics SBMT Subcommittee, focuses on research on the use of psychedelics for diverse neuropsychiatric illnesses.

The Spine Surgery SBMT subcommittee focuses on State-of-the-art diagnostic, surgical tools, and therapeutics. Some topics that we research are:
• Degenerative spine disease
• Spinal deformity (kyphosis/scoliosis)
• Spinal tumors (primary and metastatic bone tumors as well as intradural tumors)
• Spinal trauma
• Osteoporotic and geriatric spinal pathology
• Revision spinal surgery to treat failed fusions or adjacent level pathology
• Intraoperative CT scan and navigation systems
• State-of-the-art neuromonitoring
• CyberKnife radiosurgery
We specialize in traditional open and newer minimally invasive spinal techniques to treat the above pathologies.

The Visual Processing and Retinal Neuromodulation SBMT Subcommittee focuses on research on retinal processing and its impact on modulation
of autonomic, endocrine and limbic functions, visual influence on movement and behavior (including mental health diagnoses), effect of delayed visual development in autism and other developmental disabilities, visual circuitry disruptions from autonomic dysregulation, concussions and other brain injuries, advancements in optical assessments, sensory integration, virtual augmented/mixed reality.

J. Wesson Ashford

14th President of SBMT (2016-2017), WBMF Golden Axon Award, 2017 | Alzheimer's Disease and Dementia Subcommittee SBMT 2023- 2024
Dr. Ashford is a Clinical Professor of Psychiatry and Behavioral Sciences (affiliated) at Stanford University and the Director of the War Related Illness and Injury Study Center at the VA Palo Alto Health Care System. Dr. Ashford also serves as a Senior Research Scientist at the Stanford / VA Aging and Alzheimer’s Disease Clinical Research Centers. He is Chair of the Memory Screening Advisory Board of the Alzheimer’s Foundation of America and a Senior Editor of the Journal of Alzheimer’s Disease.

Warren Wilson Boling Jr

15th president of SBMT, WBMF Golden Axon Award Recipient, 2018
Warren Wilson Boling Jr., MD, FAAN, FRCSC, FRACS has been appointed chair, department of neurosurgery at Loma Linda University.

Jeffrey C. Wang

16th president of SBMT, WBMF Golden Axon Award Recipient, 2019
Dr. Wang’s reputation for consistently providing excellent patient care, outstanding qualifications and experience has earned him immense respect from patients and physicians alike.

Saleem Abdulrauf

17th president SBMT, WBMF Golden Axon Award Recipient, 2020
American physician specializing in neurosurgery in St. Louis, Missouri, who has helped develop high-flow brain bypass surgery, a less invasive procedure for treating intracranial aneurysm than methods used previously. He is the Neurosurgeon-in-Chief at the Abdulrauf Institute of Neurosurgery. He is the Founding Professor and Chairman of the Department of Neurological Surgery at Saint Louis University School of Medicine and Director of the Center for Cerebrovascular and Skull Base Surgery at Saint Louis University Hospital in Saint Louis, Missouri.

Robert Hariri

18th President of SBMT (2020-2021), WBMF Pioneer in Medicine Award, 2020 | WBMF Golden Axon Award, 2021
Dr. Hariri pioneered the use of stem cells to treat a range of life-threatening human diseases and continues today to make transformative contributions in the fields of immuno-oncology and cell therapeutics along with tissue engineering and functional regeneration. He is widely acknowledged for his discovery of pluripotent stem cells derived from the human placenta, and as a member of the team that discovered the physiological activities of tumor necrosis factor (TNF).

Jason Cormier

19th President of SBMT (2021-2022), WBMF Golden Axon Award, 2022
Dr. Cormier is a native of South Louisiana, where he graduated from St Thomas More High School in Lafayette, La. A former LSU basketball player and graduate of Louisiana State University in Baton Rouge, he went on to receive his medical degree from Louisiana State University in New Orleans, Louisiana. He became eligible for the Alpha Omega Alpha Medical Honor society and served on several committees, including the LSU School of Medicine Admissions Committee, the LSU School of Medicine Dean’s Selection Committee and was the medical school’s representative to the Louisiana Board of Supervisors in 2004. He received a number of scholarships and was a member of many different societies. Dr. Cormier also dedicated his time on a monthly basis to the Student Run Homeless clinic in New Orleans, La.

Vicky Yamamoto

20th President of SBMT (2022-2023), WBMF Golden Axon Award, 2016 | WBMF Young Investigator Award, 2009 | NeuroOncology Subcommittee SBMT 2023-2024 | Neuroscience20 Organizing Committee
Cancer Scientist, USC-Norris Comprehensive Cancer Center, USC-Keck School of Medicine, CA, USA | Executive Director of SBMT | Member of the Executive Board of the World Brain Mapping Foundation
Deborah Zelinsky, OD

Deborah Zelinsky

21st President of SBMT (2023-2024), WBMF Golden Axon Award, 2022 | Visual Processing and Retinal Modulation Subcommittee SBMT 2023-2024
Deborah Zelinsky, O.D. is an optometrist noted worldwide for her work in neuro-optometric rehabilitation. Currently, she serves as founder and executive research director of The Mind-Eye Institute, based in Northbrook, Illinois.

Meet the SBMT President

Abilash Haridas
Society for Brain Mapping and Therapeutics elects Abilash Haridas, to serve as president for the 2024-2025 cycle.